| Stage | EYE | % of rev | PWP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $499M | 100.00% | $251M | 100.00% | EYE ×1.98 |
| Gross profit | $290M | 58.23% | $76M | 30.37% | EYE +27.9pp |
| Operating income | $21M | 4.27% | $35M | 13.90% | PWP +9.6pp |
| Pre-tax income | $18M | 3.60% | $35M | 13.99% | PWP +10.4pp |
| Net income | $12M | 2.49% | $23M | 9.27% | PWP +6.8pp |
| Stage | EYE | PWP | Gap · A − B |
|---|---|---|---|
| Revenue | $499M100.00% | $251M100.00% | EYE ×1.98 |
| Gross profit | 58.23%$290M | 30.37%$76M | EYE +27.9pp |
| Operating income | 4.27%$21M | 13.90%$35M | PWP +9.6pp |
| Pre-tax income | 3.60%$18M | 13.99%$35M | PWP +10.4pp |
| Net income |
| 2.49%$12M |
| 9.27%$23M |
| PWP +6.8pp |
No shared counterparties.